COMMUNIQUÉS West-GlobeNewswire

Analogic Receives Early Termination of HSR Waiting Period
30/04/2018
PEABODY, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (NASDAQ: ALOG ) (“the Company” or “Analogic”), a provider of leading-edge healthcare and security solutions, announced that it has received notice [...]
ALAVIDA HEALTH Secures Third Round of Funding
30/04/2018
Company Offers Alternative Treatment for Problem Drinking with a 75% Success Rate VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science-based remote treatment program for Alcohol Use [...]
Orion Corporation: Managers' transactions - Agendum Oy
30/04/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 30 APRIL 2018 at 17.15 EEST Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked [...]
Bavarian Nordic A/S - Articles of Association
30/04/2018
Updated Articles of Association for Bavarian Nordic A/S Attachment BavarianNordicArticlesofAssociation.pdf
Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
30/04/2018
Approval Adds Two Additional Implants to Current Spine Labeling DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine [...]
Merit Medical to Present at Three Conferences in May
30/04/2018
SOUTH JORDAN, Utah, April 30, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]
New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions
30/04/2018
- First Data Showing Prognostic Value of Test Among Patients by Performance Status Presented at ACMQ Annual Meeting – - Optimizing Best Supportive Care and Avoiding Overtreatment Creates an Expected Savings of $955 Per [...]
Summary of capital reduction pursuant to Article 32 of the Danish Capital Markets Act
30/04/2018
Read the full announcement in the attached file Attachment 2018_20_Reduction_of_common_stock_EN
NewLink Genetics to Participate in Upcoming Investor Conferences
30/04/2018
AMES, Iowa, April 30, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) announced today that the company will participate in the following investor conferences: Deutsche Bank 43 rd Annual Health Care [...]
athenahealth to Present at the Deutsche Bank 43rd Annual Health Care Conference
30/04/2018
WATERTOWN, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Tim O’Brien, [...]
Arbutus Announces Conference Call to Provide a Corporate Update and First Quarter 2018 Financial Results
30/04/2018
VANCOUVER, British Columbia and WARMINSTER, Pa., April 30, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS ), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today [...]
Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures
30/04/2018
Nearly 1,000 patients treated with the DS1000 System Reports acceleration in two transcatheter mitral repair programs ST. LOUIS PARK, Minn., April 30, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc. , a privately-held medical [...]
Tabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE
30/04/2018
MOORESTOWN, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ: TRHC ), a healthcare technology company advancing the field of medication safety, recently signed an [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss First Quarter 2018 Financial and Operating Results
30/04/2018
BOTHELL, Wash., April 30, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Grandevo® CG and Venerate® CG Approved for Use on Cannabis by the Colorado, Washington and Nevada Departments of Agriculture
30/04/2018
Grandevo and Venerate are Effective Tools for Controlling Mites and Insect Pests DAVIS, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based [...]
Yield10 Bioscience to Host Webcast of its First Quarter 2018 Conference Call
30/04/2018
WOBURN, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new technologies to achieve step-change improvements in crop yield that enhance global food security, [...]
Ultragenyx and Kyowa Kirin Announce Crysvita® (burosumab-twza) Now Launched in the U.S. for the Treatment of X–linked Hypophosphatemia (XLH) in Children and Adults
30/04/2018
First FDA-Approved Treatment that Targets the Underlying Cause of this Rare, Hereditary, Lifelong Disease UltraCare™ Program in Place to Provide Ongoing Patient Support NOVATO, Calif., TOKYO and LONDON, April 30, 2018 ( [...]
Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Charing Cross International Symposium 2018
30/04/2018
Charing Cross Symposium (CX) is the longest running vascular and endovascular symposium in Europe and one of the largest in the world REDWOOD CITY, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR [...]
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin
30/04/2018
SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal [...]

Pages